Cognitive & Nootropic
PE 22-28
From $219 AUD · ≥98% HPLC purity · third-party COA · ships Australia-wide
What is PE 22-28?
PE 22-28 (spadin-derived peptide) is a TREK-1 potassium channel inhibitor studied in research on mood and neurogenesis. A seven-amino-acid fragment of the spadin sequence with greater TREK-1 affinity than the parent molecule, it is used as a research reference in preclinical models of antidepressant-like activity and hippocampal neurogenesis.
Specifications
- From: $219 AUD
- Category: Cognitive & Nootropic
- Form: Lyophilised powder
- Purity: ≥98% HPLC
- Testing: Third-party Certificate of Analysis
- Classification: Research reference material · For Research Use Only
Frequently asked questions
What is PE 22-28? +
PE 22-28 (spadin-derived peptide) is a TREK-1 potassium channel inhibitor studied in research on mood and neurogenesis.
What purity is TXLABS PE 22-28? +
PE 22-28 is supplied as a research reference material at ≥98% HPLC purity, batch-traceable with a third-party Certificate of Analysis available on request. For research use only — not for human or veterinary use.
Do you ship PE 22-28 within Australia? +
Yes — PE 22-28 ships Australia-wide via Australia Post (Road $10, Express $20, free Express over $600), typically dispatched 24–72 hours after payment clears. Worldwide shipping is not offered.
How is PE 22-28 stored and reconstituted? +
Lyophilised PE 22-28 is stored at -20°C, desiccated and protected from light. For research it is reconstituted with bacteriostatic water; the TXLABS reconstitution calculator helps determine concentration and syringe units.
Is PE 22-28 for human use? +
No. PE 22-28 is a laboratory reference material for in-vitro and research use only. It is not a medicine, supplement or therapeutic good, and is not for human or veterinary use.